Subarachnoid haemorrhage

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
3 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
B Haematology (ATC B) 1
H Endocrinology (ATC H) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Heparin / LMWH 1 substance
Corticosteroid 1 substance
Phase III: 1 Phase II: 1 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Rheinische Friedrich-Wilhelms-Universitaet Bonn Academic
    DEXAMETHASONE SODIUM PHOSPHATE
    2024-512314-17-00 1 country 2021 n=334
    Ended

Phase II

1 trial
  • Amsterdam UMC Stichting Academic
    NADROPARIN CALCIUM
    2024-511679-14-00 1 country 2024 n=100
    Recruiting

Phase I (First in Human)

1 trial
  • Edvince AB Commercial
    1,4-DIAMINO-2,3-DICYANO-1,4-BIS(O-AMINOPHENYLMERCAPTO)BUTADIENE HEMIETHANOLATE
    2024-514590-22-00 1 country 2022 n=51 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Edvince AB Commercial 1 Phase I (First in Human) 1
Amsterdam UMC Stichting Academic 1 Phase II 1
Rheinische Friedrich-Wilhelms-Universitaet Bonn Academic 1 Phase III 0
New trials by year
2021
1
2022
1
2024
1
← All indication landscapes